Presentation was great and highlights the diverse and complementary nature of this with current candidates.
My question regarding the modularity was that as these NK cell types are still in development could these new treatments use modular binders such as Prescient Therapeutics OmniCAR for further safety and control.
Didn't quite get the answer I was after, but good to highlight the safety of NK cells.
Presentation was great and highlights the diverse and...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $20.21K | 5.053M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2213046 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 13563373 | 20 |
View Market Depth
| Last trade - 15.01pm 24/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |